ZIRCLERIX Trademark
Trademark Overview
On Friday, March 8, 2024, a trademark application was filed for ZIRCLERIX with the United States Patent and Trademark Office. The USPTO has given the ZIRCLERIX trademark a serial number of 79400837. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 22, 2025. This trademark is owned by Telix Pharmaceuticals Limited. The ZIRCLERIX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer
Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use
General Information
| Serial Number | 79400837 |
| Word Mark | ZIRCLERIX |
| Filing Date | Friday, March 8, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, April 22, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 22, 2025 |
Trademark Statements
| Goods and Services | Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer |
| Goods and Services | Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 25, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 25, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Telix Pharmaceuticals Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Party Name | Telix Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
Trademark Events
| Event Date | Event Description |
| Thursday, July 25, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, July 30, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 30, 2024 | APPLICATION FILING RECEIPT MAILED |
| Friday, September 20, 2024 | ASSIGNED TO EXAMINER |
| Monday, September 23, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, September 23, 2024 | REFUSAL PROCESSED BY MPU |
| Sunday, September 22, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, September 23, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, October 12, 2024 | REFUSAL PROCESSED BY IB |
| Monday, March 24, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 24, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 24, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 24, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 16, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 22, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 22, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
